Association of Biotechnology Led Enterprises

News

Sanofi CEO unveils new strategy to drive company’s innovation and growth

Sanofi expects to expand its business operating income (BOI) margin 1 to 30% by 2022, with an ambition for its BOI margin to exceed 32% by 2025.

Dec 11, 2019

By : Team ABLE

Chinese investors inject $45 million into South Australia health and biotech industry

The $45 million fund is backed by a group of private investors based in Nanjing, China. The group is led by Mr An LuFan, Executive Director of D&R Pharmaceuticals.

Dec 11, 2019

By : Team ABLE

Criteria for clinical trials might be too strict, needlessly excluding patients: UT Southwestern Medical Center findings

Clinical trial eligibility criteria are designed to limit risks to study participants. But, according to Dr. Gerber, these criteria may be excessive in places.

Dec 11, 2019

By : Team ABLE

Bill & Melinda Gates Foundation CEO Sue Desmond-Hellmann to step down; Mark Suzman appointed to role

Desmond-Hellmann made the decision to step away from full-time work after concluding that she could not adequately meet the demands of the position

Dec 09, 2019

By : Team ABLE

Lilly forms new leadership and strategy in oncology R&D

The new organization, named Loxo Oncology at Lilly, will be led jointly by Josh Bilenker, Jacob Van Naarden, andNisha Nanda, and will report into Daniel Skovronsky

Dec 09, 2019

By : Team ABLE